MICHELLE SEXTON: Open Payments
NPI 1659777696 · SAINT JOSEPH, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$351 in 19 payments from 10 companies in 2025. Trend: 2023 $316 · 2024 $0 · 2025 $351
Food & beverage: $351
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $109 |
| Merck Sharp & Dohme LLC | 3 | $55 |
| Janssen Biotech, Inc. | 2 | $42 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $37 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| Genentech USA, Inc. | 1 | $22 |
| Daiichi Sankyo Inc. | 1 | $21 |
| GENZYME CORPORATION | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $14 |
| Iovance Biotherapeutics, Inc. | 1 | $12 |
Products named: ENHERTU, KEYTRUDA, ERLEADA, LIBTAYO, Tecentriq, Nubeqa, SARCLISA, Stivarga.
Industry payments across MO — which companies pay providers there.
